Higher levels of BPA in children and teens significantly associated with obesity
Researchers at NYU School of Medicine have revealed a significant association between obesity and children and adolescents with higher concentrations of urinary bisphenol A (BPA), a synthetic chemical recently banned by the ...
Overweight and Obesity
Sep 18, 2012 |
4.3 / 5 (6) |
5
|
New device may reduce repeat breast cancer surgeries
(HealthDay)—A new device meant to help surgeons determine in the operating room if they have removed all cancerous breast cancer tissue may help reduce repeat surgeries after lumpectomy without compromising ...
Cancer
Sep 12, 2012 |
not rated yet |
0
'Super tree' maps 20,000 medicinal, related plants
(Medical Xpress)—New research from the University of Reading, The Royal Botanic Gardens, Kew and Imperial College London published on 10 September in the Proceedings of the National Academy of Sciences (PNAS) ...
Medications
Sep 11, 2012 |
5 / 5 (6) |
0
|
Rare genetic disease offers insight into common cancers
Fanconi anemia is a recessive genetic disorder affecting 1 in 350,000 babies, which leaves cells unable to repair damaged DNA. This lack of repair puts Fanconi anemia patients at high risk for developing ...
Cancer
Sep 04, 2012 |
5 / 5 (2) |
0
|
FTC sending refunds over CVS business overcharging
(AP)—The Federal Trade Commission says it is mailing refund checks to 13,000 Medicare beneficiaries who were overcharged for drugs because a CVS Caremark Corp. business understated the price of the products.
Medications
Sep 04, 2012 |
not rated yet |
0
New drug approved for lack of certain white blood cells
(HealthDay)—The U.S. Food and Drug Administration has approved the drug tbo-filgrastim to treat certain cancer patients undergoing chemotherapy who have a condition called severe neutropenia, the FDA said in a news release.
Medications
Aug 30, 2012 |
not rated yet |
0
More heart problems with two chemo drugs for breast cancer
Women who have breast cancer and are treated with two chemotherapy drugs may experience more cardiac problems like heart failure than shown in previous studies, according to a new Cancer Research Network study by Group Health ...
Cancer
Aug 30, 2012 |
not rated yet |
0
Possible therapy for tamoxifen resistant breast cancer identified
(Medical Xpress)—A study by researchers at the Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) has discovered how tamoxifen-resistant ...
Cancer
Aug 30, 2012 |
not rated yet |
0
|
Daily aspirin may help fight prostate cancer, but not breast cancer
(HealthDay)—Two new studies paint a complex portrait of aspirin's impact on cancer risk and mortality, with one suggesting the drug may lower the risk of dying from prostate cancer and the other seeing ...
Cancer
Aug 27, 2012 |
not rated yet |
0
|
Researchers connect new genetic signature to leukemia
(Medical Xpress)—University of Rochester Medical Center scientists believe they are the first to identify genes that underlie the growth of primitive leukemia stem cell, and then to use the new genetic signature to identify ...
Cancer
Aug 27, 2012 |
5 / 5 (1) |
0
|
Combination peptide therapies might offer more effective, less toxic cancer treatment
Two studies suggest that two peptide agents used either together or individually with a low-dose of a standard chemotherapy drug might offer more effective cancer therapy than current standard single-drug treatments.
Cancer
Aug 16, 2012 |
not rated yet |
0
Chemotherapy during pregnancy does not appear to increase complications for newborn infants
The study examined a group of more than 400 women from across Europe who were diagnosed with early-stage breast cancer while pregnant. 197 (48%) of the women underwent chemotherapy during pregnancy, and the authors assessed ...
Obstetrics & gynaecology
Aug 15, 2012 |
not rated yet |
0
Gene deletion drives more than a quarter of breast cancers
A new study shows that the lack of a certain gene occurs in almost 28 percent of human breast cancers, playing a role in some 60,000 breast cancer cases in the United States and 383,000 worldwide this year.
Genetics
Aug 15, 2012 |
4 / 5 (3) |
1
|
Treating drug resistant cancer through targeted inhibition of sphingosine kinase
Scientists at Tulane University School of Medicine, led by Dr. James Antoon and Dr. Barbara Beckman, have characterized two drugs targeting sphingosine kinase (SK), an enzyme involved in cancer growth and metastasis. New ...
Cancer
Aug 09, 2012 |
not rated yet |
0
New Herceptin delivery method could vastly simplify breast cancer treatment
A new method of delivering a commonly used breast cancer drug could result in considerably less time spent in hospital for some women undergoing breast cancer treatment, according to the results of a Phase 3 trial published ...
Cancer
Aug 08, 2012 |
not rated yet |
0
